Report Published: "Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2013"
Global Markets Direct's, 'Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Renal Cell Carcinoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Renal Cell Carcinoma. Metastatic Renal Cell Carcinoma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's...
View full press release